Literature DB >> 2582420

Characterization of an almost full-length cDNA coding for human blood coagulation factor X.

M R Fung, C W Hay, R T MacGillivray.   

Abstract

A human liver cDNA library was screened by colony hybridization with a bovine factor X cDNA probe. Three of the positive plasmids contained overlapping DNA that coded for most of human factor X mRNA. DNA sequence analysis of these three clones allowed the prediction of the complete amino acid sequence of plasma factor X. From these studies, we predict that human factor X is synthesized as a single polypeptide chain precursor in which the light and heavy chains of plasma factor X are linked by the tripeptide Arg-Lys-Arg. The cDNA sequence also predicts that human factor X is synthesized as a preproprotein having an amino-terminal leader peptide of at least 28 amino acid residues. A comparison of the amino acid sequences of human and bovine factor X shows high sequence identity around the calcium-binding regions and catalytic regions but low sequence identity around the nonfunctional regions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582420      PMCID: PMC397831          DOI: 10.1073/pnas.82.11.3591

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The 3' terminal sequences of human alpha and beta globin messenger RNAs: comparison with rabbit globin messenger RNA.

Authors:  N J Proudfoot; J I Longley
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chain.

Authors:  K Titani; K Fujikawa; D L Enfield; L H Ericsson; K A Walsh; H Neurath
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways.

Authors:  K Fujikawa; M H Coan; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

5.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

6.  Bovine factors X 1 and X 2 (Stuart factor). Isolation and characterization.

Authors:  K Fujikawa; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

7.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

8.  Isolation of a cDNA clone for human antithrombin III.

Authors:  E V Prochownik; A F Markham; S H Orkin
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

9.  Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta.

Authors:  K Fujikawa; K Titani; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

10.  Nucleotide sequence of the rightward operator of phage lambda.

Authors:  T Maniatis; A Jeffrey; D G Kleid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

View more
  27 in total

Review 1.  Mitogens and hepatocyte growth control in vivo and in vitro.

Authors:  K S Koch; X P Lu; D A Brenner; G H Fey; A Martinez-Conde; H L Leffert
Journal:  In Vitro Cell Dev Biol       Date:  1990-11

2.  Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors.

Authors:  S Kidd; M R Kelley; M W Young
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

3.  Functional and structural characterization of factor Xa dimer in solution.

Authors:  Rima Chattopadhyay; Roxana Iacob; Shalmali Sen; Rinku Majumder; Kenneth B Tomer; Barry R Lentz
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

4.  Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.

Authors:  K Wieland; D S Millar; C B Grundy; R S Mibashan; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

Review 5.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  RFLPs for PstI and EcoRI in the human blood clotting factor X gene.

Authors:  C W Hay; K A Robertson; M R Fung; R T MacGillivray
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

7.  Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.

Authors:  D D Koeberl; C D Bottema; R P Ketterling; P J Bridge; D P Lillicrap; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

8.  Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.

Authors:  J Plescia; D C Altieri
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

9.  Precursor-product relationship between vitellogenin and the yolk proteins as derived from the complete sequence of a Xenopus vitellogenin gene.

Authors:  S Gerber-Huber; D Nardelli; J A Haefliger; D N Cooper; F Givel; J E Germond; J Engel; N M Green; W Wahli
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

10.  Factor XSanto Domingo. Evidence that the severe clinical phenotype arises from a mutation blocking secretion.

Authors:  H H Watzke; A Wallmark; N Hamaguchi; P Giardina; D W Stafford; K A High
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.